{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:51:48Z","timestamp":1761486708710},"reference-count":23,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":571,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2000,6]]},"abstract":"<jats:p>We performed a pilot study including rituximab (Mabthera; IDEC\u2010C2B8, Hoffmann\u2010La Roche) with a sequential high\u2010dose therapy protocol in 15 patients with follicular and three patients with mantle cell lymphoma and studied the potential of the chemoimmunotherapy to induce depletion of malignant B cells <jats:italic>in vivo<\/jats:italic>. Our treatment protocol included induction with three cycles of CHOP (cyclophosphamide, doxorubicin, vincristine and prednisone) chemotherapy, followed by peripheral blood stem cell (PBSC) mobilization using high\u2010dose cytosine arabinoside (2\u2003g\/m<jats:sup>2<\/jats:sup> every 12\u2003h, days 1 and 2) and mitoxantrone (10\u2003mg\/m<jats:sup>2<\/jats:sup>, days 2 and 3) (HAM), preceeded by rituximab (375\u2003mg\/m<jats:sup>2<\/jats:sup>). The proportion of CD19<jats:sup>+<\/jats:sup> B cells in blood and bone marrow decreased from 1\u00b72\u2003\u00b1\u20030\u00b74% to 0\u00b713\u2003\u00b1\u20030\u00b71% (<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b701) and from 2\u00b77\u2003\u00b1\u20030\u00b78% to 0\u00b78\u2003\u00b1\u20030\u00b75% (<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b703) respectively. The number of t(14;18)\u2010positive cells in blood and bone marrow progressively decreased with treatment, as assessed by the quantitative real\u2010time PCR assay in four patients. Conversion to PCR\u2010negativity was achieved in the peripheral blood (PB) of seven informative patients. Leucaphereses were performed during the granulocyte colony\u2010stimulating factor (G\u2010CSF)\u2010supported leucocyte recovery phase. In 17 of 18 patients, a median of 15\u00b71\u2003\u00d7\u200310<jats:sup>6<\/jats:sup> CD34<jats:sup>+<\/jats:sup> cells\/kg body weight (BW) could be harvested by a single procedure for enrichment by an immunomagnetic method. Leucapheresis products contained 51\u00b73\u2003\u00b1\u200328\u00b78\u2003\u00d7\u200310<jats:sup>4<\/jats:sup> CD19<jats:sup>+<\/jats:sup> B cells\/kg BW (mean) and were t(14;18) PCR negative in all seven informative patients. These data compare favourably with results obtained in patients treated with the same regimen without rituximab. The high\u2010dose therapy (<jats:italic>n<\/jats:italic>\u2003=\u200312 patients), including total body irradiation (14\u00b74\u2003Gy) and cyclophosphamide (200\u2003mg\/kg BW), was also preceeded by rituximab. Recovery of neutrophils to &gt;\u200a0\u00b75\u2003\u00d7\u200310<jats:sup>9<\/jats:sup>\/l and of platelets to &gt;\u200a20\u2003\u00d7\u200310<jats:sup>9<\/jats:sup>\/l required a median of 13\u00b75 and 11\u00b75\u2003d (range 11\u201324 and 9\u201324\u2003d) respectively. In conclusion, the addition of the CD20 antibody to chemotherapy ensured tumour depletion <jats:italic>in vivo<\/jats:italic> and allowed the collection of PBSCs devoid of tumour cells and with conserved engraftment capability.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2000.02084.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:25:35Z","timestamp":1047363935000},"page":"729-735","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["<i>In vivo<\/i> depletion of B cells using a combination of high\u2010dose cytosine arabinoside\/mitoxantrone and rituximab for autografting in patients with non\u2010Hodgkin's lymphoma"],"prefix":"10.1111","volume":"109","author":[{"given":"Maria Teresa","family":"Voso","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gitta","family":"Pantel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirjam","family":"Weis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Moos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony D.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer","family":"Haas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Hohaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1182\/blood.V86.8.3257.3257","article-title":"Intensive therapy with peripheral blood progenitor cell transplantation in 60 patients with poor prognosis follicular lymphoma","volume":"86","author":"Bastion Y.","year":"1995","journal-title":"Blood"},{"key":"e_1_2_6_3_1","first-page":"637","article-title":"Improved delivery of radiolabeled anti\u2010B1 monoclonal antibody to Raji lymphoma xenografts by predosing with unlabeled anti\u2010B1 monoclonal antibody","volume":"52","author":"Buchsbaum D.J.","year":"1992","journal-title":"Cancer Research"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.1.268"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.4.644"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.1997.12.177"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401489"},{"key":"e_1_2_6_8_1","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1182\/blood.V88.7.2780.bloodjournal8872780","article-title":"High dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission","volume":"88","author":"Freedman A.S.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_6_9_1","first-page":"481","article-title":"In\u2010vivo purging of circulating CD34+ progenitor cells in low\u2010grade lymphoma with rituximab and high\u2010dose therapy (Abstract)","volume":"92","author":"Gianni A.M.","year":"1998","journal-title":"Blood"},{"key":"e_1_2_6_10_1","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1182\/blood.V81.12.3449.3449","article-title":"Detection by polymerase chain reaction of residual cells with the bcl\u20102 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B cell lymphoma","volume":"81","author":"Gribben J.G.","year":"1993","journal-title":"Blood"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1994.12.8.1685"},{"key":"e_1_2_6_12_1","first-page":"149","article-title":"High\u2010dose therapy with peripheral blood progenitor cell transplantation in low\u2010grade non\u2010Hodgkin's lymphoma","volume":"17","author":"Haas R.","year":"1996","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_6_13_1","first-page":"2627","article-title":"Eradication of large human B cell tumors in nude mice with unconjugated CD20 monoclonal antibodies and interleukin 2","volume":"55","author":"Hooijberg E.","year":"1995","journal-title":"Cancer Research"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65546-0"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.10.3266"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.6.2188"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.8.2825"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401242"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V83.5.1390.1390"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.5.1644"},{"key":"e_1_2_6_21_1","doi-asserted-by":"crossref","first-page":"973","DOI":"10.4049\/jimmunol.135.2.973","article-title":"The B cell surface molecule B1 is functionally linked with B cell activation and differentiation","volume":"135","author":"Tedder T.F.","year":"1985","journal-title":"Journal of Immunology"},{"key":"e_1_2_6_22_1","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1182\/blood.V89.10.3763","article-title":"Lack of t(14;18) polymerase chain reaction\u2010positive cells in highly purified CD34+ cells and their CD19 subsets in patients with follicular lymphoma","volume":"89","author":"Voso M.T.","year":"1997","journal-title":"Blood"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01171.x"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702336"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2000.02084.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2000.02084.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2000.02084.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T09:59:27Z","timestamp":1698573567000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2000.02084.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,6]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,6]]}},"alternative-id":["10.1046\/j.1365-2141.2000.02084.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2000.02084.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,6]]},"assertion":[{"value":"2001-12-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}